Provided by Tiger Fintech (Singapore) Pte. Ltd.

Conduit Pharmaceuticals Inc.

0.6201
-0.1600-20.51%
Pre-market: 0.5980-0.0221-3.56%06:24 EDT
Volume:1.47M
Turnover:927.80K
Market Cap:4.13M
PE:-0.03
High:0.6695
Open:0.6400
Low:0.6001
Close:0.7801
Loading ...

Conduit Pharmaceuticals Files for Offering of up to $17.8 Mln of Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
19 Feb

Conduit Pharmaceuticals, Charles River Laboratories Partner to Evaluate Potential Lupus Treatment

MT Newswires Live
·
13 Feb

BRIEF-Conduit Pharmaceuticals Partners With Charles River In Systemic Lupus Erythematosus Model

Reuters
·
13 Feb

Conduit Pharmaceuticals: Study to Accelerate Development of Azd1656 for Autoimmune Disorders, Focus on Systemic Lupus Erythematosus, Lupus Nephritis

THOMSON REUTERS
·
13 Feb

Conduit Pharmaceuticals Inc: Partners With Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

THOMSON REUTERS
·
13 Feb

Conduit announces debt repayment, conversion of senior secured note

TIPRANKS
·
11 Feb

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

THOMSON REUTERS
·
11 Feb

Press Release: Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Dow Jones
·
11 Feb

Conduit Pharmaceuticals Transitions to Phase Ii of Sarborg Collaboration to Support AI-Driven Drug Development

THOMSON REUTERS
·
07 Feb

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

GlobeNewswire
·
07 Feb

Conduit Pharmaceuticals files to sell 5.9M shares of common stock for holders

TIPRANKS
·
06 Feb

Conduit Pharmaceuticals Completes Strategic Review With Sarborg to Map Revolutionizing Drug Development With Artificial Intelligence

THOMSON REUTERS
·
28 Jan

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

GlobeNewswire
·
28 Jan

Conduit Pharmaceuticals Inc trading halted, news pending

TIPRANKS
·
25 Jan

BRIEF-Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Reuters
·
23 Jan

Conduit Pharmaceuticals Inc - Approves 1-for-100 Reverse Stock Split

THOMSON REUTERS
·
23 Jan

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

THOMSON REUTERS
·
23 Jan

Conduit Pharmaceuticals Partners With Agility Life Sciences to Create Enhanced Formulations for Its Autoimmune Pipeline

THOMSON REUTERS
·
22 Jan

Conduit Pharmaceuticals partners with Agility Life Sciences

TIPRANKS
·
22 Jan

Dow Dips 500 Points; US Economy Adds 256,000 Jobs In December

Benzinga
·
10 Jan